A Review of the Association Between Parkinson Disease and Malignant Melanoma

Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [et Al.]
Max DisseSarah S Schram

Abstract

An association between melanoma and Parkinson disease (PD) has been hinted at in the neurology and oncology literature since the 1970s after the initiation of levodopa (L-DOPA) therapy for PD. Given that L-DOPA is a substrate in melanin synthesis, there existed a concern that this therapy might cause melanoma. The objective was to research possible etiological links to explain the connection between PD and melanoma. A PubMed and Google Scholar literature search was performed using access provided by the University of Minnesota biomedical library. Patients with PD have an overall decreased risk of cancer diagnoses. However, breast cancer and melanoma have an uncharacteristically high rate of co-occurrence with PD. Family history of melanoma and lighter hair and skin color confer a higher risk of developing PD, and having a first-degree relative with either disease conveys a significantly increased risk of developing the other. Other possible connections that have been explored include pigmentation genes in neural-derived cells, pesticides, MC1R polymorphisms, and abnormal cellular autophagy. Although a link between PD and melanoma exists, the etiology of this link continues to be elusive. Both PD and melanoma are likely multifac...Continue Reading

References

Dec 8, 2004·British Journal of Cancer·J H OlsenH Møller
Jun 28, 2006·Annals of Neurology·Alberto AscherioMichael J Thun
Jul 14, 2006·Epidemiology·Jørgen H OlsenKirsten Frederiksen
May 23, 2007·Movement Disorders : Official Journal of the Movement Disorder Society·Joaquim FerreiraCristina Sampaio
Feb 6, 2009·Annals of Neurology·Xiang GaoAlberto Ascherio
Jun 9, 2009·Parkinsonism & Related Disorders·J-D VermeijW E J Weber
Oct 21, 2009·Neurology·X GaoA Ascherio
Jan 8, 2010·Cancer Causes & Control : CCC·Archna BajajEva S Schernhammer
Jan 12, 2010·Movement Disorders : Official Journal of the Movement Disorder Society·Joaquim J FerreiraCristina Sampaio
Mar 10, 2010·Archives of Neurology·John M BertoniUNKNOWN North American Parkinson's and Melanoma Survey Investigators
Mar 17, 2010·Archives of Dermatology·Howard W RogersBrett M Coldiron
May 14, 2010·PloS One·Yasuhiro Matsuo, Tetsu Kamitani
Jun 10, 2010·International Journal of Cancer. Journal International Du Cancer·Richard P GallagherJohn J Spinelli
Jul 6, 2010·Mutation Research·Dominique Scherer, Rajiv Kumar
Nov 3, 2010·Annual Review of Pathology·Joshua M ShulmanMel B Feany
Apr 5, 2012·Cold Spring Harbor Perspectives in Medicine·Melinda A Lynch-DayDaniel J Klionsky
Aug 28, 2012·Molecular Neurodegeneration·Karin M DanzerPamela J McLean
Feb 26, 2013·Movement Disorders : Official Journal of the Movement Disorder Society·Stacey L KowalAnjali Jain
Mar 29, 2013·Toxicological Sciences : an Official Journal of the Society of Toxicology·Areski ChorfaThierry Baron
Oct 22, 2013·American Journal of Epidemiology·Karin WirdefeldtWeimin Ye
Oct 25, 2013·Neurotoxicity Research·Fabio A ZuccaLuigi Zecca
Jul 16, 2014·Archives of Biochemistry and Biophysics·Zalfa A Abdel-MalekSancy Leachman
Jul 16, 2014·Archives of Biochemistry and Biophysics·Carlos Iván Rodríguez, Vijayasaradhi Setaluri
Oct 7, 2014·Journal of Molecular Neuroscience : MN·Sandra Elincx-BenizriSharon Hassin-Baer

❮ Previous
Next ❯

Citations

Sep 28, 2016·Animal Genetics·N A GustafsonL A Lyons
Jul 22, 2018·Melanoma Research·Fatma Aydoğmuş-ÖztürkMuhammad I Choudhary
Jan 30, 2019·Molecular Biology Reports·Fatma Aydoğmuş-ÖztürkMuhammad Iqbal Choudhary
Apr 22, 2017·Oncotarget·Xuefei ZhuTie-Shan Tang
Sep 8, 2016·Movement Disorders Clinical Practice·Matej Skorvanek, Kailash P Bhatia
Sep 27, 2018·Brain and Behavior·Lamei YuanHao Deng
Jun 1, 2017·Movement Disorders Clinical Practice·Ildefonso Rodriguez-LeyvaMaria E Jimenez-Capdeville
Oct 1, 2017·The Biochemical Journal·Jiro OguraYangzom D Bhutia
Jul 25, 2019·Acta neurologica Belgica·Anastasia BougeaLeonidas Stefanis
Oct 18, 2020·Biomedicines·Maria EjmaGjumrakch Aliev
Nov 29, 2020·Parkinsonism & Related Disorders·Nicki NiemannJoseph Jankovic
Dec 22, 2020·Movement Disorders : Official Journal of the Movement Disorder Society·Panagiota S Filippou, Tiago F Outeiro
Feb 18, 2021·The American Journal of Dermatopathology·Saray Porcar SauraCarlos Monteagudo

❮ Previous
Next ❯

Related Concepts

Related Feeds

Parkinson's Disease & Autophagy

Autophagy leads to degradation of damaged proteins and organelles by the lysosome. Impaired autophagy has been implicated in several diseases. Here is the role of autophagy in Parkinson’s disease.

Parkinson's Disease & Autophagy (MDS)

Autophagy leads to degradation of damaged proteins and organelles by the lysosome. Impaired autophagy has been implicated in several diseases. Here is the role of autophagy in Parkinson’s disease.

Autophagy & Metabolism

Autophagy preserves the health of cells and tissues by replacing outdated and damaged cellular components with fresh ones. In starvation, it provides an internal source of nutrients for energy generation and, thus, survival. A powerful promoter of metabolic homeostasis at both the cellular and whole-animal level, autophagy prevents degenerative diseases. It does have a downside, however--cancer cells exploit it to survive in nutrient-poor tumors.

Autophagy & Disease

Autophagy is an important cellular process for normal physiology and both elevated and decreased levels of autophagy are associated with disease. Here is the latest research.

Autophagy & Model Organisms

Autophagy is a cellular process that allows degradation by the lysosome of cytoplasmic components such as proteins or organelles. Here is the latest research on autophagy & model organisms